Loading…
Back To Schedule
Tuesday, June 20 • 8:00am - 9:30am
#203: Radical Technologies: Changing the Future of Biopharmaceuticals

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Feedback form is now closed.
Component Type: Session
Level: Intermediate
CE: CME 1.50; IACET 1.50; RN 1.50

In this DIAmond session, innovative thinkers project the impact of some of the most radical emerging technologies on the future of biomedical research. From real-time patient monitoring through mHealth technology to digitally enabled precision medicine to “research as a care option” supported by advanced analytics, the expert panel will explore radical changes that will improve the biopharmaceutical development process of the future and the radical technologies that will make them possible.

Learning Objectives

Discuss the potential impact of one or more emerging new technologies on the development process and outcomes for biopharmaceutical products; Describe ways in which today's biopharmaceutical development process will be different in five years and what the impact will be for industry as well as the patient/consumer.

Chair

Craig H. Lipset, MBA

Speaker

Panelist
Jeffry G. James, MBA

Panelist
Alicia Staley, MBA, MS

Panelist
Julian M. Jenkins


Speakers
avatar for Jeffry James

Jeffry James

Chief Executive Officer, Wilmington Health and Innovo Research
Jeff James is currently the CEO of Wilmington Health in Wilmington, NC. Wilmington Health is a multispecialty group practice with 161 providers covering 37 specialties in 22 locations. He is responsible for the strategic vision and its deployment as well as all financial and operational... Read More →
JJ

Julian Jenkins

Vice President, Innovation Performance and Technology, GlaxoSmithKline
Dr. Julian Jenkins is VP ad head of Innovation, Performance and Technology at GSK R&D, which involves maintaining a state of the art clinical technology infrastructure and the innovation agenda for clinical research. He is also GSK’s representative on the TransCelerate oversight... Read More →
avatar for Craig Lipset

Craig Lipset

Head of Clinical Innovation, Global Product Development, Pfizer Inc
Craig’s is responsible for impacting clinical research through digital tools, patient engagement, and novel collaborations. He serves on the Board for the Foundation for Sarcoidosis Research and the MedStar Health Research Institute, the Operations Committee for TransCelerate, and... Read More →
avatar for Alicia Staley

Alicia Staley

Patient Advocate, Independent Patient Advocate
Alicia Staley is the Patient Advocate at Cure Forward. She is a three-time cancer survivor, first diagnosed with Hodgkin’s disease as a sophomore at Syracuse University. After 15 years in software design and information systems management, Alicia began applying her engineering background... Read More →

Tuesday June 20, 2017 8:00am - 9:30am
S100a McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  12: DIAmond, Session
  • format json
  • Featured Topics Real World Evidence,Wearables-Mobile Health,Devices-Combination Products,StudentProgramming
  • Credit Type CME, IACET, RN
  • Tags Session